DIC in COVID‐19: Implications for prognosis and treatment?
- 14 June 2020
- journal article
- letter
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 18 (7), 1798-1799
- https://doi.org/10.1111/jth.14878
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJournal of Thrombosis and Haemostasis, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Disseminated intravascular coagulation in patients with 2019‐nCoV pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsisThe Journal of Maternal-Fetal & Neonatal Medicine, 2020
- A Systematic Summary of Systematic Reviews on Anticoagulant Therapy in SepsisJournal of Clinical Medicine, 2019
- Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trialsJournal of Thrombosis and Haemostasis, 2016
- Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.2001
- High-Dose Antithrombin III in Severe SepsisJama-Journal Of The American Medical Association, 2001
- Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular CoagulationThrombosis and Haemostasis, 2001